University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices (IUD).
The University at Buffalo has partnered with The Center for Discovery (TCFD), a leading provider of medical and clinical care and education services for people with complex developmental disabilities, to advance critical research in autism and other complex conditions.
BUFFALO, N.Y. — The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is pleased to announce that William A. Prescott, Jr., PharmD ’02, has been promoted to clinical professor of pharmacy practice.
Six University at Buffalo researchers have been awarded SUNY Innovative Instruction Technology Grants (IITG) to pilot campus innovations and initiatives that have the potential to be replicated and scaled up throughout the State University of New York system (SUNY).
A manuscript by Assistant Professor of Pharmaceutical Sciences Juliane Nguyen, PharmD, PhD, titled The Phenotypic Effects of Exosomes Secreted from Distinct Cellular Sources: a Comparative Study Based on miRNA Composition, has been selected for publication in a theme issue of the American Association of Pharmaceutical Scientists (APPS) Journal: "Pioneering Pharmaceutical Science by Emerging Investigators."
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences had an impressive number of faculty, students and residents present at the 2018 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Anaheim, CA.
UB Now sat down with James M. O’Donnell, dean of the School of Pharmacy and Pharmaceutical Sciences, to learn more about the school’s strategic priorities, as well as trends in pharmacy education, research and career paths.
Dr. Juliane Nguyen is an assistant professor in the Department of Pharmaceutical Sciences at the University of Buffalo. Her Therapeutic Biomaterials Laboratory investigates using exosomes and other nanoscale carriers for the treatment of diseases including cancer and ischemic heart disease.
Robert Bies, associate professor, pharmaceutical sciences, is principal investigator on an $880,000 grant from the Food and Drug Administration for his project entitled “Physiologically-based model of the female reproductive tract: vaginal and intrauterine delivery components.”